Get the Stockscreener App
9.60
9.46%
0.83
Evolent Health Inc stock is traded at $9.60, with a volume of 5.45M.
It is up +9.46% in the last 24 hours and down -1.74% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$8.77
Open:
$8.94
24h Volume:
5.45M
Relative Volume:
1.98
Market Cap:
$1.13B
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-10.21
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
+3.23%
1M Performance:
-1.74%
6M Performance:
-7.96%
1Y Performance:
-70.08%
1-Day Range:
$8.795
$9.72
1-Week Range:
$8.57
$9.72
52-Week Range:
$7.06
$33.23
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
9.60 | 1.05B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
290.86 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
80.52 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.74 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.82 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.24 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Published on: 2025-08-20 23:34:49 - thegnnews.com
Evolent Health to offer $140M in convertible notes, Targets 2025 debt, stock buyback - MSN
Technical Heatmap Flags Evolent Health Inc. for WatchJuly 2025 Intraday Action & Low Risk High Reward Ideas - beatles.ru
Evolent prices $145 million convertible notes offering at 4.50% By Investing.com - Investing.com South Africa
Evolent Health Upsizes Convertible Notes Offering - TipRanks
Shareholders That Lost Money on Evolent Health, Inc.(EVH) Should Contact Levi & Korsinsky about Securities Fraud InvestigationEVH - ACCESS Newswire
Evolent Health prices convertible notes offering - MSN
Evolent Health Announces Pricing Of Oversubscribed And Upsized $145.0 Million Of Convertible Senior Notes Due 2031 To Repurchase Existing Notes And Class A Common Stock - MarketScreener
Evolent prices $145 million convertible notes offering at 4.50% - Investing.com
Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock - PR Newswire
Evolent Health (EVH) Bolsters Management Team - MSN
Evolent Health announces $140M convertible senior notes offering - TipRanks
Evolent Health announces $140 million convertible notes offering - Investing.com
Evolent Health announces proposed offering of $140 million of convertible senior notes - MarketScreener
$140M Debt Offering: Evolent Health Launches Convertible Notes to Refinance Debt and Buy Back Stock - Stock Titan
Lost Money on Evolent Health, Inc.(EVH)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
What machine learning models say about Evolent Health Inc.2025 Fundamental Recap & Accurate Trade Setup Notifications - Newser
Understanding Evolent Health Inc.’s price movement2025 Market WrapUp & Expert Approved Trade Ideas - Newser
Evolent Health Inc. stock trendline breakdownJuly 2025 EndofMonth & Safe Entry Trade Reports - Newser
Will Evolent Health Inc. continue its uptrendPortfolio Return Report & Weekly High Momentum Picks - Newser
Should you buy the dip on Evolent Health Inc.Market Activity Report & Growth Focused Stock Reports - thegnnews.com
Evolent Health’s Earnings Call: Balancing Growth and Challenges - MSN
Tools to assess Evolent Health Inc.’s risk profile2025 Market Overview & Breakout Confirmation Alerts - Newser
Evolent Health, Inc. (EVH) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire
Engaged Capital's Q2 Moves: Freshpet Stake, Evolent Health Boost, Portillo's Reduction - AInvest
An Investigation Has Commenced on Behalf of Evolent Health, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your EVH Losses - ACCESS Newswire
5 Insightful Analyst Questions From Evolent Health’s Q2 Earnings Call - Yahoo Finance
How Evolent Health’s Steep Revenue Drop and Forecast Will Impact EVH Investors - simplywall.st
Evolent Health’s SWOT analysis: stock faces challenges, shows resilience - Investing.com India
Brookdale, Evolent Health, Fortrea, 10x Genomics, and Organon Stocks Trade Up, What You Need To Know - Yahoo Finance
Evolent Health’s SWOT analysis: stock faces challenges, shows resilience By Investing.com - Investing.com India
Shareholder Rights Advocates at Levi & Korsinsky Investigate Evolent Health, Inc. (EVH) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Evolent Health at Canaccord Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Is This the Dip to Buy in Evolent Health Inc.Weekly Stock Recap & Low Volatility Stock Recommendations - 선데이타임즈
Evolent Health, Inc. (NYSE:EVH) Q2 2025 Earnings Call Transcript - Insider Monkey
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know - TradingView
EVH ACTIVE INVESTIGATION: Contact Levi & Korsinsky If You Lost Money On Your Evolent Health, Inc. investment - ACCESS Newswire
Candlestick Reversal Detected on Evolent Health Inc.’s ChartFast Gaining Stock Screener Reports Released - beatles.ru
EVH Q2 Deep Dive: Revenue Falls Short, Guidance Cut as Margin Initiatives Continue - Yahoo Finance
Evolent Health, Inc. SEC 10-Q Report - TradingView
Lost Money on Evolent Health, Inc.(EVH)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
Evolent Health’s Strong Financial Performance and Optimistic Future Outlook Earns Buy Rating - TipRanks
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $14 - 富途牛牛
Further Weakness as Evolent Health (NYSE:EVH) Drops 9.8% This Week, Taking Three-year Losses to 74% - 富途牛牛
How volatile is Evolent Health Inc. stockCapital Doubling Stock Strategy - mustnews.co.kr
Evolent Health's Strategic Position in the Evolving Managed Care Landscape - AInvest
Evolent Health, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:EVH) - Seeking Alpha
Should Evolent Health's (EVH) Declining Sales and Rising Losses Prompt Investor Reassessment of 2025 Outlook? - simplywall.st
Protect Your Investment: Contact Levi & Korsinsky About the Evolent Health, Inc. (EVH) Investigation - TradingView
Evolent Health (EVH) Stock Falls 13.9% on Disappointing Q2 ResultsNews and Statistics - IndexBox
Why Evolent Health (EVH) Stock Is Nosediving - TradingView
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.72%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):